Vieworks, a global leader in advanced X-ray imaging and industrial vision systems, has announced the successful completion of a large-scale expansion at its Hwaseong manufacturing campus, significantly increasing production capacity and operational flexibility to meet growing global demand. This strategic investment …
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, announced that its state-of-the-art current Good Manufacturing Practice ("c…
Cencora, a global pharmaceutical solutions company, announced plans to invest $1 billion through 2030 to bolster and expand its pharmaceutical distribution network in the United States. The investments — headlined by the opening of its second national distribution center in Ohio and an expanded presence in Alabama and…
October 2025 witnessed an exceptional surge in pharmaceutical and life sciences investments, underscoring global momentum in innovation, regional job creation, and supply chain localization. Leading organizations — including AstraZeneca, Eli Lilly, Moderna, Simtra BioPharma Solutions, ACG, Rentschler Biopharma, Ypsom…
Jungbunzlauer, a global leader in high-quality ingredients from natural sources, announced the successful closing of its acquisition of the production site in Thomson, Illinois from International Flavors & Fragrances, Inc. (IFF). This milestone marks Jungbunzlauer's first U.S. manufacturing facility, enhancing i…
Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound care manufacturing site in Changshu, China. This strategic investment marks a milestone in Mölnlycke's growth journey and the beginning of localised manufacturing in one of the worl…
Eli Lilly and Company announced plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, located within the Leiden Bio Science Park. This major project will expand Lilly's capacity to produce oral medicines and strengthen the company's global supply chain. The facility will incorporate adva…
Sai Life Sciences Limited, one of India’s fastest growing Contract Research, Development, and Manufacturing Organizations (CRDMO), announced the groundbreaking for a new CMC Process R&D Center at its integrated R&D campus in Hyderabad. Scheduled for completion by September 2026, the facility will double the co…
Eli Lilly and Company announced a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico. This new investment will integrate advanced technologies and expand production capacity within the existing campus to support the company's growing po…
Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, is making progress on a dual-continent expansion strategy to meet growing global demand for complex, high-value therapies. Simtra's expansion in Halle/Westfalen, Germany, continues in …
Page 13 of 57